# Warfarin and Antiplatelet Vascular Evaluation

> **NCT00125671** · PHASE3 · UNKNOWN · sponsor: **Anand, Sonia, M.D.** · enrollment: 2400 (—)

## Conditions studied

- Peripheral Vascular Diseases
- Cardiovascular Diseases

## Interventions

- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT00125671
- **Lead sponsor:** Anand, Sonia, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-01
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 2400 (—)
- **Last updated:** 2009-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125671, "Warfarin and Antiplatelet Vascular Evaluation". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00125671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*